Amid the ongoing uncertainties over the role of combination therapy in the treatment of hypothyroidism, endocrinology experts have issued a consensus statement that new clinical trials are warranted ...
The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Up to 30% of patients with HF have some form of thyroid dysfunction that may ...
We’ve finally had a chance to get our hands on the Fujifilm X-T4, and it’s impressive to say the least. But how does it stack up to its predecessor, the X-T3, and which is right for you? The X-T4 ...
The new, advanced excipient base delivers superior flowability, exceptional uniformity and enhanced stability — cutting compounding time in half. PCCA UniFlow™ The new, advanced excipient base ...
Phase II Study of Ipilimumab, Nivolumab, and Panitumumab in Patients With KRAS/NRAS/BRAF Wild-Type Microsatellite Stable Metastatic Colorectal Cancer Neoadjuvant chemotherapy (NAC) is increasingly ...
Vivo launched the T4 Ultra in India earlier today with some significant improvements over its predecessor, the T3 Ultra. While the on-paper specs and features of the Vivo T4 Ultra look promising, its ...
The thyroid TRK-T3 oncogene, produced by a chromosomal translocation, is a chimeric, constitutively activated version of the NTRK1/NGF receptor and it is able to transform NIH3T3 cells and ...
Triiodothyronine may be a novel treatment for chronic congestive heart failure, according to Irwin Klein, MD. T3 has a powerful effect on almost every process in the body, including heart rate, ...
The indications for definitive chemoradiotherapy for patients with severe dysphagia caused by oesophageal carcinoma are poorly defined. Dysphagia is a major symptom that affects the quality of life in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback